Breaking News
0

AbbVie Inc (ABBV)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow AbbVie's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
80.020 +1.270    +1.61%
22/02 - Closed. Currency in USD ( Disclaimer )
After Hours
79.520
-0.500
-0.625%
17:52:33 - Real-time Data
Type: Equity
Market: United States
ISIN: US00287Y1091 
CUSIP: 00287Y109
  • Volume: 5,022,750
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 78.244 - 80.190
AbbVie 80.020 +1.270 +1.61%

ABBV Overview

 
Information about the AbbVie Inc Stock. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close78.75
Day's Range78.244 - 80.19
Revenue48.97B
Open79.16
52 wk Range75.77 - 122
EPS3.72
Volume5,022,750
Market Cap121.17B
Dividend (Yield)4.28 (5.43%)
Average Vol. (3m)6,976,782
P/E Ratio21.52
Beta1.15
1-Year Change - 31.93%
Shares Outstanding1,514,272,698
Next Earnings DateApr 25, 2019
What is your sentiment on AbbVie?
or
Market is currently closed. Voting is open during market hours.

AbbVie Inc News


AbbVie Inc Analysis


Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Buy Buy Buy Sell Neutral
Technical Indicators Strong Buy Strong Buy BUY Sell Strong Sell
Summary Strong Buy Strong Buy Buy Sell Sell

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Bullish doji Star 1M Current
Completed Patterns
Bullish doji Star 1W 3 Jan 27, 2019
Falling Three Methods 1M 4 Oct 18
Morning Doji Star 1M 6 Aug 18

AbbVie Inc Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  NYSE 80.020 0.000 0.000 5,022,750 +1.61% USD 22/02  
  London 70.39 0.00 0.00 1 -21.47% EUR 22/02  
  Mexico 1,528.00 1,527.00 2,000.00 2,728 +3.15% MXN 22/02  
  Berlin 70.550 0.000 0.000 0 +1.82% EUR 22/02  
  Stuttgart 69.140 0.000 0.000 70 -0.38% EUR 22/02  
  Frankfurt 69.56 70.22 70.38 224 +0.81% EUR 22/02  
  TradeGate 70.13 70.40 70.82 1,993 +1.45% EUR 22/02  
  Munich 69.750 0.000 0.000 0 -0.92% EUR 22/02  
  BM&FBovespa 296.87 0.00 0.00 300 -0.99% BRL 22/02  

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  Apple 172.97 173.00 171.38 +1.91 +1.12% 18.91M 22/02  
  Alphabet A 1,116.56 1,117.25 1,100.50 +12.35 +1.12% 1.47M 22/02  
  Facebook 161.89 162.41 160.31 +1.85 +1.16% 15.86M 22/02  
  Vale ADR 12.500 12.510 12.170 +0.470 +3.91% 20.25M 22/02  
  Petroleo Brasileiro Petrobras ADR 16.63 16.75 16.53 -0.02 -0.12% 11.55M 22/02  
  Cleveland-Cliffs 11.580 11.640 11.420 +0.070 +0.61% 5.61M 22/02  
  Amazon.com 1,631.56 1,634.94 1,621.17 +12.12 +0.75% 3.10M 22/02  
  Alibaba 176.92 177.02 172.52 +5.26 +3.06% 16.18M 22/02  
  Tesla 294.71 296.50 292.10 +3.48 +1.19% 5.74M 22/02  
  Kraft Heinz 34.95 36.00 34.51 -13.23 -27.46% 135.20M 22/02  

AbbVie Inc Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

30000

Equity Type

ORD

AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture and sale of a range of pharmaceutical products. Its products are focused on treating conditions, such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease and multiple sclerosis; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis, and other serious health conditions. It offers products in various categories, including HUMIRA (adalimumab), Oncology products, Virology Products, Additional Virology products, Metabolics/Hormones products, Endocrinology products and other products, which include Duopa and Duodopa (carbidopa and levodopa), Anesthesia products and ZINBRYTA (daclizumab).

Read More

Start Trading With Top Industry Brokers

Brokers Regulation Minimum Deposit
U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States) $0 Start Trading
U.S. Commodity Futures Trading Commission (United States) Start Trading
U.S. Commodity Futures Trading Commission (United States) $250 Start Trading
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ABBV Comments

Write your thoughts about AbbVie Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Ilya Atomiq
Ilya Atomiq Nov 01, 2018 7:06AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What's going on?
Reply
2 0
Herb Tuerr
Herb Tuerr Oct 09, 2018 2:45AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
It's a buy and the dividend is a bonus. Also in the pipeline is cannabis.
Reply
9 0
Ilya Atomiq
Ilya Atomiq Oct 01, 2018 10:24AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
AbbVie expects $35 billion in non-Humira revenue by 2025. The company made $28.2 billion last year with Humira in the mix. The stock is trading at less than 11 times expected earnings, making AbbVie one of the best healthcare picks around
Reply
2 0
Dave Timcina
Dave Timcina Sep 19, 2018 11:07PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
is abbv worth buying?
Reply
2 0
Ilya Atomiq
Ilya Atomiq Sep 19, 2018 11:07PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Yes
Reply
2 0
Romio Ding
Romio Ding Jul 30, 2018 9:28AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
hope to see good news
Reply
1 0
iraj zarin
iraj zarin Jul 19, 2018 9:44AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
salam..dostan nazareton chie
Reply
0 1
Mori Gh
Mori Gh Jul 19, 2018 9:44AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Salam 98
Reply
0 1
Jul 19, 2018 9:44AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The yield is 95% for 30 seconds. on binary options https://clk.su/yOlCO
Reply
0 2
Ali Samadi
Ali Samadi Feb 08, 2018 10:15AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
150 in 3 month
Reply
2 0
Ali Samadi
Ali Samadi Feb 08, 2018 10:15AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
140* correction
Reply
1 0
coach Shez
coach Shez Feb 08, 2018 10:15AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Bad prediction
Reply
0 0
Ilya Kurishko
Ilya Kurishko Oct 27, 2017 9:22AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what is going on? Good reports and drop bby 6 USD?? where is the logic
Reply
0 0
Роман Ерин
Роман Ерин Oct 27, 2017 9:22AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Idk, but maybe report was worse than forecast
Reply
0 0
Ali Samadi
Ali Samadi Sep 24, 2017 11:00AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
100 in 2 month
Reply
1 0
Terry Robins
Terry Robins Sep 24, 2017 11:00AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Agree, watch for an announcement ob stock split
Reply
0 0
Marco Bebawi
Marco Bebawi Sep 15, 2017 2:09PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I hope so i bought 50 share
Reply
0 0
Richard McGeorge
Richard McGeorge Sep 15, 2017 12:34PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
It will make it yet hang on
Reply
0 0
Douglas Kaplan
Douglas Kaplan Feb 09, 2017 2:31PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I thought this stock had a very good future, I am doubting myself now? It was on track to be close to $100.00 in 2017.
Reply
0 0
Aaron Robinson
Aaron Robinson Feb 09, 2017 2:31PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What happened to it? What marijuana stock is good to buy for a penny stocks
Reply
0 0
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email